Cytokinetics, Incorporated (CYTK)

Cytokinetics Stock Forecast

Stock Price Forecast

The 19 analysts that cover Cytokinetics stock have a consensus rating of "Strong Buy" and an average price target of $89.26, which forecasts a 40.90% increase in the stock price over the next year. The lowest target is $56 and the highest is $136.

Price Target: $89.26 (+40.90%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$56	$89.26	$92	$136
Change	-11.60%	+40.90%	+45.22%	+114.68%

Analyst Ratings

The average analyst rating for Cytokinetics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	6	6	7	7	7	7
Buy	8	8	9	9	10	10
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	16	18	18	19	19

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yanan Zhu Wells Fargo	Wells Fargo	Buy Initiates $95	Buy	Initiates	$95	+49.96%	Apr 10, 2026
Gena Wang Barclays	Barclays	Buy Maintains $87 → $95	Buy	Maintains	$87 → $95	+49.96%	Apr 6, 2026
Salim Syed Mizuho	Mizuho	Buy Maintains $84 → $100	Buy	Maintains	$84 → $100	+57.85%	Mar 18, 2026
Tessa Romero JP Morgan	JP Morgan	Buy Maintains $74 → $75	Buy	Maintains	$74 → $75	+18.39%	Mar 17, 2026
Ashwani Verma UBS	UBS	Hold Maintains $61 → $69	Hold	Maintains	$61 → $69	+8.92%	Mar 6, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

94.53M

Increased by 7.37%

from 88.04M

Revenue Next Year

387.73M

Increased by 310.19%

from 94.53M

EPS This Year

-6.60

from -6.54

EPS Next Year

-4.84

from -6.60

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	70.43M	94.59M	7.53M	18.47M	88.04M	94.53M	387.73M
Revenue Growth	26.15%	34.31%	-92.04%	145.34%	376.56%	7.37%	310.19%
EPS	-2.80	-4.33	-5.45	-5.26	-6.54	-6.60	-4.84
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	22	21

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031	2032	2033
High	191.5M	527.7M
Avg	94.5M	387.7M
Low	58.8M	308.6M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	117.5%	458.3%
Avg	7.4%	310.2%
Low	-33.2%	226.5%

EPS Forecast

EPS	2026	2027	2028	2029	2030	2031	2032	2033
High	-5.96	-3.43
Avg	-6.60	-4.84
Low	-7.09	-5.72

EPS Growth

EPS Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.